The challenging financial environment of 2022 will lead to an increase in partnerships, according to representatives of the two big Swiss biopharma companies, Roche Holding AG and Novartis AG.
New and updated preclinical and clinical data presented by biopharma firms at the American Academy of Dermatology annual meeting, including: Arcutis, Dermavant, Janssen, Leo, Nimbus, Sun, Timber.
RSS
